V. Savci et Ih. Ulus, CARDIOVASCULAR EFFECTS OF CENTRAL CHOLINE DURING ENDOTOXIN-SHOCK IN THE RAT, Journal of cardiovascular pharmacology, 30(5), 1997, pp. 667-675
The cardiovascular effects of intracerebroventricular (i.c.v.) adminis
tration of choline were studied in endotoxin-treated rats. Intravenous
(i.v.) endotoxin (20 mg/kg) caused a moderate hypotension and tachyca
rdia within 10 min of treatment. Choline (50, 100, and 150 mu g; i.c.v
.) increased blood pressure and decreased heart rate in this condition
in a dose-dependent manner. Mecamylamine (50 mu g; i.c.v.) pre treatm
ent prevented the presser and bradycardic responses to choline, wherea
s atropine (10 mu g; i.c.v.) failed to alter both responses. Atropine
pretreatment, alone, inhibited endotoxin-induced hypotension. The pres
ser responses to choline in endotoxin-treated rats were attenuated by
pretreatment with hemicholinium-3 (20 mu g; i.c.v.), a high-affinity n
euronal choline-uptake inhibitor. Plasma vasopressin levels of endotox
in-treated rats were severalfold higher than those of control animals,
and choline (50-150 mu g; i.c.v.) produced further increases in plasm
a vasopressin in this condition. Mecamylamine abolished vasopressin re
sponse to endotoxin as well as to choline. The vasopressin receptor an
tagonist, ylene-propionyl(1)-O-Me-Tyr(2),Arg(8))-vasopressin (10 mu g/
kg; i.v.) administered 5 min after choline decreased blood pressure fr
om the increased level to the precholine levels but did not alter brad
ycardia. These results indicate that, in rats treated with endotoxin,
choline increases blood pressure and decreases heart rate by a presyna
ptic mechanism leading to the activation of central nicotinic choliner
gic pathways. An increase in plasma vasopressin levels seems to be inv
olved in the presser, but not in the bradycardic response, to choline.